Yuen Maggie 4

What Happened

• Maggie Yuen, a director of AtriCure, received a restricted stock award of 6,144 shares on May 18, 2026. The shares were granted at $0.00 per share (total reported value $0) as an equity award rather than a purchase or sale.

Key Details

• Transaction date: 2026-05-18; Filing date: 2026-05-20 (Form 4 accession 0001796057-26-000008). Filing appears timely (within the standard two-business-day window).
• Transaction type/code: Award/Grant (A); Price per share: $0.00; Shares acquired: 6,144.
• Shares owned after transaction: Not stated in the provided filing excerpt.
• Footnote: The shares were issued under the AtriCure, Inc. 2023 Stock Incentive Plan and will vest on the one-year anniversary of the grant date (per footnote F1).

Context

• This was a restricted stock grant (compensation), not an open-market purchase or sale. Such awards are common for board compensation and vest over time; they do not by themselves indicate buying or selling intent.